224 related articles for article (PubMed ID: 22190492)
61. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
Ogiso H; Ishitani R; Nureki O; Fukai S; Yamanaka M; Kim JH; Saito K; Sakamoto A; Inoue M; Shirouzu M; Yokoyama S
Cell; 2002 Sep; 110(6):775-87. PubMed ID: 12297050
[TBL] [Abstract][Full Text] [Related]
62. Revisiting a controversy: The effect of EGF on EGFR dimer stability.
Singh DR; King C; Salotto M; Hristova K
Biochim Biophys Acta Biomembr; 2020 Jan; 1862(1):183015. PubMed ID: 31295474
[TBL] [Abstract][Full Text] [Related]
63. Molecular dynamics analysis of conserved hydrophobic and hydrophilic bond-interaction networks in ErbB family kinases.
Shih AJ; Telesco SE; Choi SH; Lemmon MA; Radhakrishnan R
Biochem J; 2011 Jun; 436(2):241-51. PubMed ID: 21426301
[TBL] [Abstract][Full Text] [Related]
64. Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: local stimulation using magnetic microspheres as assessed by quantitative digital microscopy.
Friedländer E; Arndt-Jovin DJ; Nagy P; Jovin TM; Szöllosi J; Vereb G
Cytometry A; 2005 Oct; 67(2):161-71. PubMed ID: 16163699
[TBL] [Abstract][Full Text] [Related]
65. ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases.
Spencer KS; Graus-Porta D; Leng J; Hynes NE; Klemke RL
J Cell Biol; 2000 Jan; 148(2):385-97. PubMed ID: 10648571
[TBL] [Abstract][Full Text] [Related]
66. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
[TBL] [Abstract][Full Text] [Related]
67. Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns.
Wosikowski K; Schuurhuis D; Johnson K; Paull KD; Myers TG; Weinstein JN; Bates SE
J Natl Cancer Inst; 1997 Oct; 89(20):1505-15. PubMed ID: 9337347
[TBL] [Abstract][Full Text] [Related]
68. The emergence of ErbB2 expression in cultured rat hepatocytes correlates with enhanced and diversified EGF-mediated signaling.
Scheving LA; Zhang L; Stevenson MC; Kwak ES; Russell WE
Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G16-25. PubMed ID: 16769812
[TBL] [Abstract][Full Text] [Related]
69. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling.
Graus-Porta D; Beerli RR; Hynes NE
Mol Cell Biol; 1995 Mar; 15(3):1182-91. PubMed ID: 7532277
[TBL] [Abstract][Full Text] [Related]
70. Coclustering of ErbB1 and ErbB2 revealed by FRET-sensitized acceptor bleaching.
Szabó A; Szöllosi J; Nagy P
Biophys J; 2010 Jul; 99(1):105-14. PubMed ID: 20655838
[TBL] [Abstract][Full Text] [Related]
71. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.
Franklin MC; Carey KD; Vajdos FF; Leahy DJ; de Vos AM; Sliwkowski MX
Cancer Cell; 2004 Apr; 5(4):317-28. PubMed ID: 15093539
[TBL] [Abstract][Full Text] [Related]
72. c-Src trafficking and co-localization with the EGF receptor promotes EGF ligand-independent EGF receptor activation and signaling.
Donepudi M; Resh MD
Cell Signal; 2008 Jul; 20(7):1359-67. PubMed ID: 18448311
[TBL] [Abstract][Full Text] [Related]
73. Cyclic stretch activates p38 SAPK2-, ErbB2-, and AT1-dependent signaling in bladder smooth muscle cells.
Nguyen HT; Adam RM; Bride SH; Park JM; Peters CA; Freeman MR
Am J Physiol Cell Physiol; 2000 Oct; 279(4):C1155-67. PubMed ID: 11003596
[TBL] [Abstract][Full Text] [Related]
74. Identification of the domain in ErbB2 that restricts ligand-induced degradation.
Shen F; Lin Q; Childress C; Yang W
Cell Signal; 2008 Apr; 20(4):779-86. PubMed ID: 18255265
[TBL] [Abstract][Full Text] [Related]
75. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research.
Earp HS; Dawson TL; Li X; Yu H
Breast Cancer Res Treat; 1995 Jul; 35(1):115-32. PubMed ID: 7612898
[TBL] [Abstract][Full Text] [Related]
76. Secondary dimerization between members of the epidermal growth factor receptor family.
Gamett DC; Pearson G; Cerione RA; Friedberg I
J Biol Chem; 1997 May; 272(18):12052-6. PubMed ID: 9115272
[TBL] [Abstract][Full Text] [Related]
77. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
Xian W; Rosenberg MP; DiGiovanni J
Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
[TBL] [Abstract][Full Text] [Related]
78. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.
Tao RH; Maruyama IN
J Cell Sci; 2008 Oct; 121(Pt 19):3207-17. PubMed ID: 18782861
[TBL] [Abstract][Full Text] [Related]
79. Mechanistic Insights into R776H Mediated Activation of Epidermal Growth Factor Receptor Kinase.
Ruan Z; Kannan N
Biochemistry; 2015 Jul; 54(27):4216-25. PubMed ID: 26101090
[TBL] [Abstract][Full Text] [Related]
80. Mapping ErbB receptors on breast cancer cell membranes during signal transduction.
Yang S; Raymond-Stintz MA; Ying W; Zhang J; Lidke DS; Steinberg SL; Williams L; Oliver JM; Wilson BS
J Cell Sci; 2007 Aug; 120(Pt 16):2763-73. PubMed ID: 17652160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
